- The Washington Times - Wednesday, May 10, 2006

The Washington Times on April 28 incorrectly reported the approval process for a test that provides an accurate prediction of a man’s risk for recurrent prostate cancer. Food and Drug Administration approval is not required for the diagnostic test Prostate PX.

LOAD COMMENTS ()

 

Click to Read More

Click to Hide